Monday February 18, 2019 05:42

Heathcare Press Release : 30 Jun 2014

Masimo Announces Support for the Every Newborn Action Plan to Reduce Global Newborn Heathcare—30 Jun 14

Masimo's iSpO2 Rx Mobile Pulse Oximetry Technology Ideal for Early Detection of Health Conditions in Newborns in Low-Resource Settings Masimo (NASDAQ: MASI) today announced its unconditional commitment to the Every Newborn Action Plan (ENAP), a global

Verita Life Shares Its Approach on How to Stop Making Cancer with Bangkok Heathcare—30 Jun 14

Verita Life recently hosted more than 40 Bangkok residents at the Grand Hyatt Erawan to discuss how healthy living and integrated oncology can help an increasing number of cancer cases in Thailand. “Reclaim Your Health: Stop Making Cancer,”

Verita Life Redefines Cancer Treatment With the Launch of Its Flagship Integrative Oncology Centre Heathcare—30 Jun 14

The first of its kind in Thailand, the centre offers unified scientifically medical treatments and natural healing therapies to target and eliminate cancer, effectively reverse and stop cancer development and enhance immunity. The foundation of these

CHMP Recommends Lilly and Boehringer Ingelheim#s New Insulin Glargine Product for Approval in the Heathcare—30 Jun 14

The Committee for Medicinal Products for Human Use (CHMP) today issued a positive opinion recommending approval for the investigational compound LY2963016, a new insulin glargine product, for the treatment of type 1 and type 2 diabetes. The new insulin

Taiho Pharmaceutical Announces Results from TAS-102 Global Phase III RECOURSE Trial in Refractory Heathcare—30 Jun 14

- TAS-102 Demonstrated Statistically Significant Improvement in Overall Survival and Progression-free Survival - - Study Findings form Foundation for Regulatory Submissions in U.S. and Europe - Taiho Pharmaceutical Co., Ltd. announced on June 30